<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Oncohematology</journal-id><journal-title-group><journal-title xml:lang="en">Oncohematology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкогематология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1818-8346</issn><issn publication-format="electronic">2413-4023</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78</article-id><article-id pub-id-type="doi">10.17650/1818-8346-2011-6-4-12-18</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>HEMATOLOGIC MALIGNANCIES: DIAGNOSIS, TREATMENT, SUPPORTIVE CARE</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ГЕМОБЛАСТОЗЫ: ДИАГНОСТИКА, ЛЕЧЕНИЕ, СОПРОВОДИТЕЛЬНАЯ ТЕРАПИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Epidemiology of childhood lymphomas in Moscow region (population-based study)</article-title><trans-title-group xml:lang="ru"><trans-title>Медико-частотные характеристики лимфом у детей Московской области (популяционное исследование)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kachanov</surname><given-names>D. Yu.</given-names></name><name xml:lang="ru"><surname>Качанов</surname><given-names>Д. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of oncology and hematology</p></bio><bio xml:lang="ru"><p>Кафедра онкологии и гематологии</p></bio><email>totti111@list.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Abdullaev</surname><given-names>R. T.</given-names></name><name xml:lang="ru"><surname>Абдуллаев</surname><given-names>Р. Т.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Department of oncology and hematology</p></bio><bio xml:lang="ru"><p>Кафедра онкологии и гематологии</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shamanskaya</surname><given-names>T. V.</given-names></name><name xml:lang="ru"><surname>Шаманская</surname><given-names>Т. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dobrenkov</surname><given-names>K. V.</given-names></name><name xml:lang="ru"><surname>Добреньков</surname><given-names>К. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Klimova</surname><given-names>E. Yu.</given-names></name><name xml:lang="ru"><surname>Климова</surname><given-names>Е. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Inushkina</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Инюшкина</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Varfolomeeva</surname><given-names>S. R.</given-names></name><name xml:lang="ru"><surname>Варфоломеева</surname><given-names>С. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian National Research Medical University&#13;
&#13;
Federal Research Center of Pediatric Hematology, Oncology and Immunology</institution></aff><aff><institution xml:lang="ru">Российский национальный исследовательский медицинский университет им. Н.И. Пирогова Минздравсоцразвития России&#13;
&#13;
ФГБУ ФНКЦ ДГОИ им. Дмитрия Рогачева Минздравсоцразвития России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Russian National Research Medical University&#13;
&#13;
Scientific and Applied Center for the Treatment of Children with Craniofacial and Neurological Disorders</institution></aff><aff><institution xml:lang="ru">Российский национальный исследовательский медицинский университет им. Н.И. Пирогова Минздравсоцразвития России&#13;
&#13;
3Научно-практический центр медицинской помощи детям с пороками развития челюстно-лицевой области и врожденными заболеваниями нервной системы Департамента здравоохранения Москвы</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Federal Research Center of Pediatric Hematology, Oncology and Immunology</institution></aff><aff><institution xml:lang="ru">ФГБУ ФНКЦ ДГОИ им. Дмитрия Рогачева Минздравсоцразвития России</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Federal Research Center of Pediatric Hematology, Oncology and Immunology&#13;
&#13;
Moscow Regional Oncological Hospital</institution></aff><aff><institution xml:lang="ru">ФГБУ ФНКЦ ДГОИ им. Дмитрия Рогачева Минздравсоцразвития России&#13;
&#13;
Московский областной онкологический диспансер</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2011-11-23" publication-format="electronic"><day>23</day><month>11</month><year>2011</year></pub-date><volume>6</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>12</fpage><lpage>18</lpage><history><date date-type="received" iso-8601-date="2014-07-23"><day>23</day><month>07</month><year>2014</year></date><date date-type="accepted" iso-8601-date="2014-07-23"><day>23</day><month>07</month><year>2014</year></date></history><permissions><copyright-year>2011</copyright-year><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncohematology.abvpress.ru/ongm/article/view/78">https://oncohematology.abvpress.ru/ongm/article/view/78</self-uri><abstract xml:lang="en"><p>The aim of the study was to analyze the main epidemiologic characteristics of lymphomas in children 0–14 years of age in Moscow Region (MR). The database of childhood population-based cancer registry of MR served as a data source. 136 cases of lymphomas were identified during 2000–2008 years. Hodgkin disease constitutes of 55.8 % of cases. Age-standardized incidence rate (ASR) of all types of lymphomas was 1.47 per 100,000 children. ASR of Hodgkin disease was 0.77 per 100,000 children; ASR of non-Hodgkin’s lymphomas was 0.70 per 100,000 children. Distinct epidemiologic features of Hodgkin disease in different gender's and age groups were shown. 5-year observed survival (OS) of all patients with lymphomas was 0.83 ± 0.03. 5-year OS of patients with Hodgkin disease and non-Hodgkin lymphomas was 0.86 ± 0.04 and 0.80 ± 0.05 respectively.</p></abstract><trans-abstract xml:lang="ru"><p>Целью исследования был анализ медико-частотных характеристик лимфом у детей 0–14 лет на территории Московской области (МО). Источником информации служила база данных Детского популяционного канцер-регистра МО. За период 2000–2008 гг. выявлено 136 случаев заболевания. В структуре заболеваемости лимфомами превалировала лимфома Ходжкина (ЛХ) – 55,8 %. Стандартизированный по возрасту показатель заболеваемости (СПЗ) лимфомами у детей составил – 1,47 на 100 тыс. детского населения. СПЗ ЛХ у детей был равен 0,77 на 100 тыс. детского населения, СПЗ неходжкинскими лимфомами (НХЛ) – 0,70 на 100 тыс. детского населения. Показаны особенности заболеваемости детей ЛХ в зависимости от пола и возраста. Пятилетняя наблюдаемая выживаемость (НВ) детей с лимфомами была равна 0,83 ± 0,03. Пятилетняя НВ при ЛХ и НХЛ составила 0,86 ± 0,04 и 0,80 ± 0,05 соответственно.</p></trans-abstract><kwd-group xml:lang="en"><kwd>children</kwd><kwd>Hodgkin disease</kwd><kwd>non-Hodgkin’s lymphomas</kwd><kwd>incidence</kwd><kwd>survival</kwd><kwd>cancer registry</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>лимфома Ходжкина</kwd><kwd>неходжкинские лимфомы</kwd><kwd>заболеваемость</kwd><kwd>выживаемость</kwd><kwd>канцер-регистр</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Percy C.L., Smith M.A., Linet M. et al. Lymphomas and reticuloendotelial neoplasms. In: Ries L.A.G., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L., Bunin G.R. (eds). Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD, 1999. P. 35–50.</mixed-citation><mixed-citation xml:lang="ru">Percy C.L., Smith M.A., Linet M. et al. Lymphomas and reticuloendotelial neoplasms. In: Ries L.A.G., Smith M.A., Gurney J.G., Linet M., Tamra T., Young J.L., Bunin G.R. (eds). Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, MD, 1999. P. 35–50.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Kaatsch P., Spix C. German Childhood Cancer Registry – annual report 2006/07 (1980–2006). Institute of Medical Biostatistics, Epidemiology and Informatics, University of Mainz, Germany, 2008. www.kinderkrebsregister.de. [access 01.12.2010].</mixed-citation><mixed-citation xml:lang="ru">Kaatsch P., Spix C. German Childhood Cancer Registry – annual report 2006/07 (1980–2006). Institute of Medical Biostatistics, Epidemiology and Informatics, University of Mainz, Germany, 2008. www.kinderkrebsregister.de. [access 01.12.2010].</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Stiller C.A., Parkin D.M. Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull 1996;52(4):682–703.</mixed-citation><mixed-citation xml:lang="ru">Stiller C.A., Parkin D.M. Geographic and ethnic variations in the incidence of childhood cancer. Br Med Bull 1996;52(4):682–703.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Злокачественные новообразования в России в 2008 году (заболеваемость и смертность). Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М., 2010. C. 225–253.</mixed-citation><mixed-citation xml:lang="ru">Злокачественные новообразования в России в 2008 году (заболеваемость и смертность). Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М., 2010. C. 225–253.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Gatta G., Zigon G., Capocaccia R., et al. EUROCARE Working Group. Survival of European children and young adults with cancer diagnosed 1995–2002. Eur J Cancer 2009;45(6):992–1005.</mixed-citation><mixed-citation xml:lang="ru">Gatta G., Zigon G., Capocaccia R., et al. EUROCARE Working Group. Survival of European children and young adults with cancer diagnosed 1995–2002. Eur J Cancer 2009;45(6):992–1005.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Феоктистов Р.И., Румянцева Ю.В., Абугова Ю.Г. и др. Результаты лечения детей и подростков с лимфомой Ходжкина: данные моноцентрового исследования. Онкогематол 2010;2:6–12.</mixed-citation><mixed-citation xml:lang="ru">Феоктистов Р.И., Румянцева Ю.В., Абугова Ю.Г. и др. Результаты лечения детей и подростков с лимфомой Ходжкина: данные моноцентрового исследования. Онкогематол 2010;2:6–12.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Шаманская Т.В. Дескриптивная эпидемиология гемобластозов у детей и подростков Московской области. Автореф. дис. …к.м.н. М., 2005.</mixed-citation><mixed-citation xml:lang="ru">Шаманская Т.В. Дескриптивная эпидемиология гемобластозов у детей и подростков Московской области. Автореф. дис. …к.м.н. М., 2005.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Fritz A., Percy C., Jack A. et al. (eds.). International Classification of Diseases for Oncology, 3rd ed. Geneva: World Health Organization, 2000.</mixed-citation><mixed-citation xml:lang="ru">Fritz A., Percy C., Jack A. et al. (eds.). International Classification of Diseases for Oncology, 3rd ed. Geneva: World Health Organization, 2000.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Steliarova-Foucher E., Stiller C., Lacour B., Kaatsch P. International Classification of Childhood Cancer, 3rd ed. Cancer 2005;103:1457–67.</mixed-citation><mixed-citation xml:lang="ru">Steliarova-Foucher E., Stiller C., Lacour B., Kaatsch P. International Classification of Childhood Cancer, 3rd ed. Cancer 2005;103:1457–67.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Clavel J., Steliarova-Foucher E., Berger C. et al. Hodgkin's disease incidence and survival in European children and adolescents (1978–1997): report from the Automated Cancer Information System project. Eur J Cancer 2006;42(13):2037–49.</mixed-citation><mixed-citation xml:lang="ru">Clavel J., Steliarova-Foucher E., Berger C. et al. Hodgkin's disease incidence and survival in European children and adolescents (1978–1997): report from the Automated Cancer Information System project. Eur J Cancer 2006;42(13):2037–49.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Izarzugaza M.I., Steliarova-Foucher E., Martos M.C., Zivkovic S. Non-Hodgkin's lymphoma incidence and survival in European children and adolescents (1978–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42(13):2050–63.</mixed-citation><mixed-citation xml:lang="ru">Izarzugaza M.I., Steliarova-Foucher E., Martos M.C., Zivkovic S. Non-Hodgkin's lymphoma incidence and survival in European children and adolescents (1978–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42(13):2050–63.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Stiller C.A., Marcos-Gragera R., Ardanaz E. et al. Geographical patterns of childhood cancer incidence in Europe, 1988–1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42(13):1952–60.</mixed-citation><mixed-citation xml:lang="ru">Stiller C.A., Marcos-Gragera R., Ardanaz E. et al. Geographical patterns of childhood cancer incidence in Europe, 1988–1997. Report from the Automated Childhood Cancer Information System project. Eur J Cancer 2006;42(13):1952–60.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Савва Н.Н., Зборовская А.А., Алейникова О.В. Злокачественные новообразования у детей Республики Беларусь. Заболеваемость, выживаемость, смертность, паллиативная помощь. Минск, 2008. С. 22–27.</mixed-citation><mixed-citation xml:lang="ru">Савва Н.Н., Зборовская А.А., Алейникова О.В. Злокачественные новообразования у детей Республики Беларусь. Заболеваемость, выживаемость, смертность, паллиативная помощь. Минск, 2008. С. 22–27.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14. Grufferman S., Delzell E. Epidemiology of Hodgkin's disease. Epidemiol Rev 1984;6:76– 106.</mixed-citation><mixed-citation xml:lang="ru">Grufferman S., Delzell E. Epidemiology of Hodgkin's disease. Epidemiol Rev 1984;6:76– 106.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15. Stiller C.A. What causes Hodgkin's disease in children? Eur J Cancer 1998;34(4):523–8.</mixed-citation><mixed-citation xml:lang="ru">Stiller C.A. What causes Hodgkin's disease in children? Eur J Cancer 1998;34(4):523–8.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
